🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Background: GM1 gangliosidosis is a disorder that destroys nerve cells. It...
Status
Recruiting
Location
National Institutes of Health Clinical Center
Start Date
2019-08-19
Trial ID
NCT03952637
Treatments Being Tested
Gliomas are the most common malignant brain tumors, which are often associa...
Status
Recruiting
Location
Rasoul Akram hospital
Start Date
2024-11-25
Trial ID
NCT06687681
Treatments Being Tested
B cell acute lymphoblastic leukemia (B-ALL)/Lymphoblastic lymphoma (LBL) is...
Status
Not Yet Recruiting
Location
The First Affiliated Hospital, College of Medicine, Zhejiang University
Start Date
2025-03-01
Trial ID
NCT06861348
Treatments Being Tested
This phase I trial tests the safety, side effects and best dose of FH-WT1-E...
Status
Recruiting
Location
Fred Hutch/University of Washington Cancer Consortium
Start Date
2026-09-01
Trial ID
NCT07645469
Treatments Being Tested
The purpose of this study will be to determine the efficacy and the prognos...
Status
Completed
Location
University Hospitals Cleveland Medical Center
Start Date
2017-10-18
Trial ID
NCT03523000
Neurofilament Light Chain Protein (NfL) has been found by many studies as a...
Status
Completed
Location
University Hospital Hradec Kralove
Start Date
2023-12-07
Trial ID
NCT05399602
1. Protocol Title - A Comparison of Epidural Analgesia with Standard Care F...
Status
Terminated
Location
Duke University Hospital
Start Date
2013-10
Trial ID
NCT01986946
Treatments Being Tested
Due to different study designs, the sponsor separated Part C into this sepa...
Status
Terminated
Location
University of Alabama at Birmingham
Start Date
2015-12-23
Trial ID
NCT04958642
Treatments Being Tested
Background: Mature T-cell malignancies (TCMs) are a rare group of cancers ...
Status
Completed
Location
National Institutes of Health Clinical Center
Start Date
2020-12-17
Trial ID
NCT04447027
Background: Burkitt Lymphoma (BL) and diffuse large B-cell lymphoma (DLBCL...
Status
Terminated
Location
National Institutes of Health Clinical Center
Start Date
2022-03-24
Trial ID
NCT04933617